Randomized, controlled phase II study of post-surgery radiotherapy combined with recombinant adenoviral human p53 gene therapy in treatment of oral cancer.
about
The potential for tumor suppressor gene therapy in head and neck cancerMoving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.Expression of B-cell translocation gene 2 is associated with favorable prognosis in hepatocellular carcinoma patients and sensitizes irradiation-induced hepatocellular carcinoma cell apoptosis in vitro and in nude miceRecombinant adenovirus-p53 (Gendicine) sensitizes a pancreatic carcinoma cell line to radiation.Historical and Clinical Experiences of Gene Therapy for Solid Cancers in China.Key points of basic theories and clinical practice in rAd-p53 ( Gendicine ™) gene therapy for solid malignant tumors.Personalizing Medicine in Head and Neck Squamous Cell Carcinoma: The Rationale for Combination TherapiesInhibition of autophagy induced by TSA sensitizes colon cancer cell to radiation.Surgery combined with adenoviral p53 gene therapy for treatment of non-small cell lung cancer: a phase II study.p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma.
P2860
Q28066254-2E2C73D3-0614-43D8-9632-F971E238739CQ31043365-1F51094A-4E9A-48D9-807B-444F75E6F2CAQ33598354-0B9381C1-85A0-48ED-B449-6C28614139E9Q37413649-40A5A272-EF51-4879-901C-EDF35C35D2D2Q37724094-25E72C5D-A40E-48BB-B87E-E67652ADA01DQ38286386-EE38CDB0-3E37-4EE2-B57A-EF826676A547Q38586956-85E91BFD-4C2D-4EB5-85D5-2F5676967F62Q39079713-D13EA292-D66D-46DC-8A39-6A69E8C5416DQ47122526-FBD58B67-BB6D-4D28-98C7-195262F625BEQ55669873-65ED0084-9F67-44FA-9905-77EBF7826C38
P2860
Randomized, controlled phase II study of post-surgery radiotherapy combined with recombinant adenoviral human p53 gene therapy in treatment of oral cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Randomized, controlled phase I ...... y in treatment of oral cancer.
@en
type
label
Randomized, controlled phase I ...... y in treatment of oral cancer.
@en
prefLabel
Randomized, controlled phase I ...... y in treatment of oral cancer.
@en
P2093
P2860
P356
P1433
P1476
Randomized, controlled phase I ...... y in treatment of oral cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/CGT.2013.30
P577
2013-05-31T00:00:00Z
P6179
1043525860